NCT00110188 - Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

August 31, 2007

Conditions

Prostate Cancer

Interventions

DRUG

ridaforolimus

Trial Locations (4)

University of Wisconsin, Madison, WI, Madison

The Methodist Hospital Research Institute, Houston

Louis Warchaw Prostate Cancer Center, Cedars-Sinai Medical Center, Los Angeles

Beth Israel Deaconess Medical Center/MGH/DFCI, Boston